STAT3 and neoplasm: Mice lacking Stat3 signalling specifically within KrasG12D-mutant tumour cells not only display increased tumour initiation and tumour cell proliferation but also accelerated malignant progression and ultimately markedly reduced survival compared to mice with intact Stat3 signalling.